Mielofibrosis: evaluación casuística institucional: oportunidad de nuevos tratamientos

Bengio, Raquel

Mielofibrosis: evaluación casuística institucional: oportunidad de nuevos tratamientos / Myelofibrosis: institutional casuistic evaluation: opportunity for new treatments

Bengio, Raquel.

Bengio, Raquel; Academia Nacional de Medicina. Instituto de Investigaciones Hematológicas Mariano R. Castex. AR

Bol. Acad. Nac. Med. B.Aires ; 89(1): 121-134, ene.-jun. 2011. ilus, tab, graf

Article in Spanish | LILACS | ID: lil-646722

Subject(s)

Humans; Male; Female; Protein Kinase Inhibitors/administration & dosage; Protein Kinase Inhibitors/therapeutic use; Primary Myelofibrosis/diagnosis; Primary Myelofibrosis/genetics; Primary Myelofibrosis/drug therapy; Erythropoietin/therapeutic use; Immunologic Factors/therapeutic use; /genetics; Mutation; Prognosis; Receptors, Thrombopoietin/genetics; Translocation, Genetic

Search on Google

XML

Index: LILACS (Americas) Main subject: Protein Kinase Inhibitors / Primary Myelofibrosis Type of study: Prognostic study Limits: Female / Humans / Male Language: Spanish Journal: Bol. Acad. Nac. Med. B.Aires Journal subject: Medicine Year: 2011 Type: Article / Congress and conference Affiliation country: Argentina Institution/Affiliation country: Academia Nacional de Medicina/AR

Similar

MEDLINE

LILACS

LIS

Search on Google

XML